Find Expert Doctors on Progressive Supranuclear Palsy492 top medical experts on Progressive Supranuclear Palsy across 34 countries and 30 U.S. states, including 386 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Progressive Supranuclear Palsy: A degenerative disease of the central nervous system characterized by balance difficulties; ocular motility disorders (supranuclear ophthalmoplegia); dysarthria; swallowing difficulties; and axial dystonia. Onset is usually in the fifth decade and disease progression occurs over several years. Pathologic findings include neurofibrillary degeneration and neuronal loss in the dorsal mesencephalon; subthalamic nucleus; RED nucleus; pallidum; dentate nucleus; and vestibular nuclei. (From Adams et al., Principles of Neurology, 6th ed, pp1076-7)
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Basal Ganglia Diseases (3,177), Movement Disorders (2,573), Ophthalmoplegia (2,307), Tauopathies (1,975).
- Clinical Trials
: at least 116 including 4 Active, 55 Completed, 36 Recruiting - Synonyms: Progressive Supranuclear Ophthalmoplegia, Progressive Supranuclear Ophthalmoplegia, Progressive Supranuclear Palsy 1, Steele-Richardson-Olszewski Syndrome
- Josephs, Keith A Neurology
Department of Neurology, Mayo Clinic, Rochester, MN, USA. Electronic address: . Top HospitalRelevant US NIH Grant Funding: $7,262,795 over the last 5 yearsSubjects: Supranuclear Palsy, Progressive; Brain; Carbolines; Diffusion Tensor Imaging; Neurodegenerative Diseases; Parkinsonian DisordersCategories: Pathology; Physiopathology; Diagnosis; Genetics; Metabolism; Diagnostic Imaging - Boxer, Adam L Neurology Memory and Aging Center, Department of Neurology, University of California, San Francisco, CA, USA. Top HospitalRelevant US NIH Grant Funding: $14,945,068 over the last 5 yearsMedical school: New York University School of Medicine (MD, 1998)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 62/100Disclosed payments in 2021 from 4 biomedical companies, totalling $5,820, including $4,440 from F. Hoffmann-La Roche AGSubjects: Supranuclear Palsy, Progressive; Brain; Disease Progression; Frontotemporal Dementia; Tauopathies; Tau ProteinsCategories: Pathology; Diagnostic Imaging; Drug Therapy; Genetics; Diagnosis; Cerebrospinal Fluid
- Dickson, Dennis W Anatomic Pathology Department of Neuroscience, Mayo Clinic Florida, Jacksonville, Florida, USA. Top HospitalRelevant US NIH Grant Funding: $6,340,579 over the last 5 yearsSubjects: Supranuclear Palsy, Progressive; Brain; Tau Proteins; Tauopathies; Alzheimer Disease; Genetic Predisposition to DiseaseCategories: Genetics; Pathology; Metabolism; Diagnosis; Physiopathology; Diagnostic Imaging
- Litvan, Irene Neurology University of California, Parkinson and Other Movement Disorders Center, San Diego, CA, USA.Disclosed payments in 2021 from 8 biomedical companies, totalling $103.18, including $52.34 from ACADIA Pharmaceuticals IncSubjects: Supranuclear Palsy, Progressive; Tau Proteins; Cognition Disorders; Antibodies, Monoclonal, Humanized; Brain; Mental DisordersCategories: Genetics; Physiopathology; Therapeutic Use; Diagnosis; Etiology; Complications
- Golbe, Lawrence I Neurology Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.Disclosed payments from biomedical company (UCB SA) in 2021 for $1,625Subjects: Supranuclear Palsy, Progressive; Tau Proteins; Antibodies, Monoclonal, Humanized; Biomarkers; Practice Guidelines as Topic; TauopathiesCategories: Genetics; Diagnosis; Physiopathology; Drug Therapy; Therapeutic Use; Epidemiology
- Rabinovici, Gil D Neurology Memory and Aging Center, Department of Neurology, Sandler Neurosciences Center, University of California, San Francisco. Top HospitalMedical school: Northwestern University Feinberg Medical School (MD, 2001)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 62/100Disclosed payments in 2021 from 4 biomedical companies, totalling $9,075, including $3,480 from F. Hoffmann-La Roche AGSubjects: Supranuclear Palsy, Progressive; Alzheimer Disease; Tau Proteins; Brain; Cerebral Cortex; Frontotemporal DementiaCategories: Pathology; Diagnostic Imaging; Cerebrospinal Fluid; Diagnosis; Drug Therapy; Physiopathology
- Grossman, Murray Neurology Penn Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA. Top HospitalRelevant US NIH Grant Funding: $6,864,907 over the last 5 yearsDisclosed payments in 2021 from 2 biomedical companies, totalling $1,375, including $1,375 from Takeda Pharmaceuticals U.S.A., Inc.Subjects: Supranuclear Palsy, Progressive; Brain; Tau Proteins; Parkinsonian Disorders; Tauopathies; Antibodies, Monoclonal, HumanizedCategories: Pathology; Genetics; Physiopathology; Diagnosis; Diagnostic Imaging; Statistics & Numerical Data
- Jack, Clifford R Diagnostic Radiology Department of Radiology, Mayo Clinic, Rochester, MN, United States. Top HospitalRelevant US NIH Grant Funding: $641,593 over the last 5 yearsSubjects: Supranuclear Palsy, Progressive; Brain; Carbolines; Diffusion Tensor Imaging; Alzheimer Disease; Cerebral CortexCategories: Pathology; Methods; Diagnosis; Diagnostic Imaging; Metabolism; Physiopathology
- Trojanowski, John Q Anatomic Pathology Center for Neurodegenerative Disease Research CNDR, Institute On Aging and Department of Pathology & Laboratory Medicine, University of Pennsylvania, 3600 Spruce Street, 3 Maloney Building, Philadelphia, PA, 19104-4283, USA. . Top HospitalSubjects: Supranuclear Palsy, Progressive; Alzheimer Disease; Brain; Basal Ganglia; Cerebral Cortex; Neurodegenerative DiseasesCategories: Pathology; Genetics; Metabolism; Complications; Diagnostic Imaging; Methods
- Pantelyat, Alexander Neurology Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA. Top HospitalRelevant US NIH Grant Funding: $4,574,682 over the last 5 yearsDisclosed payments from biomedical company (ACADIA Pharmaceuticals Inc) in 2021 for $1,375Subjects: Supranuclear Palsy, Progressive; Parkinsonian Disorders; Alzheimer Disease; Apolipoproteins E; Biomarkers; BrainCategories: Genetics; Physiopathology; Pathology; Diagnosis; Diagnostic Imaging; Standards
- Irwin, David J Neurology Penn Frontotemporal Degeneration Center, Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA. Top HospitalSubjects: Supranuclear Palsy, Progressive; Brain; Parkinsonian Disorders; Basal Ganglia; Cerebral Cortex; Cognitive DysfunctionCategories: Pathology; Physiopathology; Diagnosis; Diagnostic Imaging; Methods; Physiology
- Wszolek, Zbigniew K Neurology Department of Neurology, Mayo Clinic, Jacksonville, FL, USA. Top HospitalSubjects: Supranuclear Palsy, Progressive; Tau Proteins; Brain; Genetic Predisposition to Disease; Hypotension, Orthostatic; Lewy Body DiseaseCategories: Genetics; Pathology; Diagnosis; Metabolism; Diagnostic Imaging; Methods
- Boeve, Bradley F Neurology Department of Neurology, Mayo Clinic Minnesota, Rochester, MN, 55905, USA. Top HospitalRelevant US NIH Grant Funding: $419,685 over the last 5 yearsSubjects: Supranuclear Palsy, Progressive; Brain; Neurodegenerative Diseases; Tau Proteins; Adaptor Proteins, Signal Transducing; Basal Ganglia DiseasesCategories: Genetics; Pathology; Metabolism; Physiopathology; Diagnosis; Therapy
- Roberson, Erik D Neurology Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, Alzheimers Disease Center, University of Alabama at Birmingham, Birmingham, AL. Top HospitalMedical school: Baylor College of Medicine (MD, 1999)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 72.3/100Disclosed payments from biomedical company (Eli Lilly and Company) in 2021 for $1,650Subjects: Supranuclear Palsy, Progressive; Alzheimer Disease; Cognition Disorders; Parkinson Disease; Tau Proteins; BrainCategories: Metabolism; Psychology; Drug Therapy; Diagnostic Imaging; Genetics; Administration & Dosage
- Geschwind, Daniel H Neurology Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, California, USA. Top HospitalRelevant US NIH Grant Funding: $3,742,439 over the last 5 yearsDisclosed payments from biomedical company (MITSUBISHI TANABE PHARMA HOLDINGS AMERICA, INC.) in 2021 for $70.85Subjects: Supranuclear Palsy, Progressive; Alzheimer Disease; Frontotemporal Dementia; Tauopathies; Brain; Genetic Predisposition to DiseaseCategories: Genetics; Pathology; Metabolism; Therapy
- Miller, Bruce L Internal Medicine Memory and Aging Center, University of California at San Francisco, San Francisco, CA, United States.Relevant US NIH Grant Funding: $11,961,626 over the last 5 yearsSubjects: Supranuclear Palsy, Progressive; Alzheimer Disease; Frontotemporal Dementia; Brain; Tauopathies; Tau ProteinsCategories: Pathology; Genetics; Diagnostic Imaging; Cerebrospinal Fluid; Complications; Diagnosis
- Seeley, William W Neurology Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA. Top HospitalMedical school: University of California, San Francisco School of Medicine (MD, 1999)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 62/100Subjects: Supranuclear Palsy, Progressive; Brain; Frontotemporal Dementia; Alzheimer Disease; Aphasia, Primary Progressive; AutopsyCategories: Pathology; Diagnostic Imaging; Complications; Cerebrospinal Fluid; Diagnosis; Metabolism
- Tsai, Richard M Neurology Memory and Aging Center, Department of Neurology, Sandler Neurosciences Center, University of California, San Francisco. Top HospitalPhysician Clinical TrialRelevant US NIH Grant Funding: $351,290 over the last 5 yearsSubjects: Supranuclear Palsy, Progressive; Brain; Tau Proteins; Alzheimer Disease; Carbolines; Caudate NucleusCategories: Diagnostic Imaging; Drug Therapy; Cerebrospinal Fluid; Pathology; Administration & Dosage; Metabolism
- Scholz, Sonja W Internal Medicine Department of Neurology, Johns Hopkins University Medical Center, Baltimore, MD, USA; Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. Top HospitalPhysicianRelevant US NIH Grant Funding: $2,626,423 over the last 5 yearsSubjects: Supranuclear Palsy, Progressive; Multiple System Atrophy; Alzheimer Disease; Apolipoproteins E; Dementia; Genetic Predisposition to DiseaseCategories: Genetics; Mortality
- Uitti, Ryan J Neurology Department of Neurology, Mayo Clinic, Jacksonville, FL, USA. Top HospitalDisclosed payments from biomedical company (BOSTON SCIENTIFIC CORPORATION) in 2021 for $525Subjects: Supranuclear Palsy, Progressive; Tau Proteins; Brain; Cognitive Dysfunction; DNA-Binding Proteins; Genetic Predisposition to DiseaseCategories: Genetics; Pathology; Diagnosis; Metabolism; Physiopathology; Epidemiology
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.